The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Soffer Gad since year 2005.
The trader's CIK number is 1612090.
At the time of this reporting, Soffer Gad is the EVP & Chief Strategy Officer of Atara Biotherapeutics, Inc. .
(stock ticker symbol ATRA).
See this page for all insider trading activities at Atara Biotherapeutics, Inc. .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2018-02-15 | ATRA | Atara Biotherapeutics, Inc. | Option Ex | 2,764 | .00 | 0 |
| 2017-11-15 | ATRA | Atara Biotherapeutics, Inc. | Option Ex | 4,146 | .00 | 0 |
| 2017-11-17 | ATRA | Atara Biotherapeutics, Inc. | Sale | 7,000 | 15.00 | 105,000 |
| 2017-08-15 | ATRA | Atara Biotherapeutics, Inc. | Option Ex | 4,145 | .00 | 0 |
| 2017-08-15 | ATRA | Atara Biotherapeutics, Inc. | Sale | 7,000 | 15.00 | 105,000 |
| 2017-08-16 | ATRA | Atara Biotherapeutics, Inc. | Sale | 2,464 | 14.53 | 35,801 |
| 2017-05-16 | ATRA | Atara Biotherapeutics, Inc. | Sale | 5,674 | 15.19 | 86,188 |
| 2017-05-15 | ATRA | Atara Biotherapeutics, Inc. | Sale | 7,000 | 15.13 | 105,910 |
| 2017-05-15 | ATRA | Atara Biotherapeutics, Inc. | Option Ex | 10,556 | .00 | 0 |
| 2017-03-10 | ATRA | Atara Biotherapeutics, Inc. | Sale | 2,500 | 20.00 | 50,000 |
| 2017-02-15 | ATRA | Atara Biotherapeutics, Inc. | Option Ex | 13,762 | .00 | 0 |
| 2017-02-14 | ATRA | Atara Biotherapeutics, Inc. | Sale | 7,000 | 15.22 | 106,540 |
| 2017-02-16 | ATRA | Atara Biotherapeutics, Inc. | Sale | 7,273 | 15.62 | 113,604 |
| 2017-02-10 | ATRA | Atara Biotherapeutics, Inc. | Sale | 6,274 | 15.78 | 98,972 |
| 2016-11-17 | ATRA | Atara Biotherapeutics, Inc. | Sale | 1,480 | 18.41 | 27,246 |
| 2016-11-16 | ATRA | Atara Biotherapeutics, Inc. | Sale | 7,136 | 19.27 | 137,510 |
| 2016-11-15 | ATRA | Atara Biotherapeutics, Inc. | Option Ex | 13,761 | .00 | 0 |
| 2016-11-14 | ATRA | Atara Biotherapeutics, Inc. | Sale | 9,582 | 20.55 | 196,910 |
| 2016-08-15 | ATRA | Atara Biotherapeutics, Inc. | Option Ex | 13,761 | .00 | 0 |
| 2016-08-16 | ATRA | Atara Biotherapeutics, Inc. | Sale | 5,356 | 21.70 | 116,198 |
| 2016-05-16 | ATRA | Atara Biotherapeutics, Inc. | Option Ex | 13,761 | .00 | 0 |
| 2016-05-17 | ATRA | Atara Biotherapeutics, Inc. | Sale | 5,427 | 15.91 | 86,343 |
| 2016-02-17 | ATRA | Atara Biotherapeutics, Inc. | Sale | 5,711 | 16.60 | 94,802 |
| 2016-02-16 | ATRA | Atara Biotherapeutics, Inc. | Option Ex | 13,761 | .00 | 0 |
| 2015-11-16 | ATRA | Atara Biotherapeutics, Inc. | Option Ex | 13,762 | .00 | 0 |
| 2015-11-17 | ATRA | Atara Biotherapeutics, Inc. | Sale | 7,586 | 31.39 | 238,139 |
| 2015-08-18 | ATRA | Atara Biotherapeutics, Inc. | Sale | 7,711 | 49.52 | 381,848 |
| 2015-08-17 | ATRA | Atara Biotherapeutics, Inc. | Option Ex | 16,538 | 3.67 | 60,644 |
| 2015-08-17 | ATRA | Atara Biotherapeutics, Inc. | Sale | 8,778 | 50.00 | 438,900 |
| 2015-05-15 | ATRA | Atara Biotherapeutics, Inc. | Option Ex | 102,239 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Soffer Gad (EVP & Chief Strategy Officer of Atara Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.